{"name":"ST Pharm Co., Ltd.","slug":"st-pharm-co-ltd","ticker":"","exchange":"","domain":"stpharm.com","description":"ST Pharm Co., Ltd. is a biopharmaceutical company focused on the development of innovative therapies. The company's pipeline includes four drug candidates, with a particular emphasis on antiviral treatments in various stages of clinical development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-29","type":"earnings","source":"simplywall.st","summary":"NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Has Found A Path To Profitability - simplywall.st","headline":"NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Has Found A Path To Profitability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPdUw3ai1ydUVwMENSbUt4bXdYcnFsWWVTbnVuc2dEN0E2V1RSZ3RpdmxoOUttSHJReXQzUHdjYzhTMW1fMzc1U1NBNVlRLXRoXzd1emhuUmpHRkdJMDhfY3p1YWdZeEc3QndGUDUyaFFqamhBLWx3VW5wVTgwek9BY0xTSEhWV19Ed3FEWncxLTVLQkFta3ZKbWNXb3A2alUwNzNsZThhanc3UWdPQ0d2NUJSODR6T2JzSWpvZjM5QkZKWV9kc21vaVBhelpDUml6Ny12TXlabnppV0lZaEtzakRreWVoUk44NTRkbg?oc=5","date":"2026-03-18","type":"pipeline","source":"Sixth Street","summary":"Paratek Pharmaceuticals to Combine with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform - Sixth Street","headline":"Paratek Pharmaceuticals to Combine with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-05","type":"earnings","source":"simplywall.st","summary":"Ono Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st","headline":"Ono Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2026-02-02","type":"pipeline","source":"simplywall.st","summary":"ST Pharm Co.,Ltd. (KOSDAQ:237690) Stocks Shoot Up 39% But Its P/S Still Looks Reasonable - simplywall.st","headline":"ST Pharm Co.,Ltd. (KOSDAQ:237690) Stocks Shoot Up 39% But Its P/S Still Looks Reasonable","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPcmVZb2RCdVM4OEVXaWF3amhPckVzQlZidUdNRzc3dlpJSHN2NnZSdnJGa1dGWDZLUEk1ZVBSbFE0NzNSZm1mellMUnhRTjI4STBZM2VsN1g0a0tYdGdhQUpZTW14RnJnZkZfWXZjVDUtVk1fSTJTNFdpYUdpTnlmby1UekhXU0V0Q2JVMlpBcGVLd2xZaDdtUGZZZjdQRnlvMFN4RTQ5bWF1amwxajdrMWpB?oc=5","date":"2026-01-27","type":"deal","source":"PharmiWeb.com","summary":"ST Pharm Wins $56 Million Oligonucleotide API Supply Deal with US Biotech - PharmiWeb.com","headline":"ST Pharm Wins $56 Million Oligonucleotide API Supply Deal with US Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQZWdJRWZ4eW8taHl3Ui1FOW5JN2cxb3FCNXZlSHotamhXMXUzcnk4NWFkeWFBa3lvMDg2ZGdMQVNXOVVPanVjWnZqaV9yVzNlc3hKdThUVXk1anF6dXZ3QnFzNnZ4dUMtM3ZoS0pkMDNLYVVhaUEtV1BCMUpYRWx0SmFHYmJMZ0MyMzc4X1U4QklGRTA?oc=5","date":"2026-01-23","type":"deal","source":"Fierce Pharma","summary":"ST Pharm inks $56M deal to produce API for a US biotech - Fierce Pharma","headline":"ST Pharm inks $56M deal to produce API for a US biotech","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-22","type":"pipeline","source":"simplywall.st","summary":"Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) Shares Climb 28% But Its Business Is Yet to Catch Up - simplywall.st","headline":"Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) Shares Climb 28% But Its Business Is Yet to Catch Up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOQUhtNGJFbGZEZWpqQXJlUTJQM1NOVVpUMTRWdHVkRS1iWGhKQ0otSGdnVmRMMVp4SW9HcjlKaFBHWXBncUdsQWtrM0dfUkVaRzVvNV9hTUF6Z3VxZlFtWDZROWQxckN0M3k0d1loa0FCMmRQNk1ZaEVNZjVuRDVFaTJ6SE5tNlpEOXg2ZXRqSkROYi1WcVE?oc=5","date":"2025-01-09","type":"pipeline","source":"MarketsandMarkets","summary":"Oligonucleotide CDMO Market Report 2024-2029, By Service, Development, and Geo - MarketsandMarkets","headline":"Oligonucleotide CDMO Market Report 2024-2029, By Service, Development, and Geo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5UNkctMFM4bkVrYVhOazU3NjBvamxmOW9ONEJWVDFvakFIeDk4Z29QOXdzUk9UcHlWZ0JMUTV5WEFSVEgxTC1mV2Q2Zkpnb0JxUldmR3EtYks3X3VmS2xNWTI4VHlqUUY1c2xCcGpn0gFyQVVfeXFMTVo0VjZJVnc2dmJDZWpFbklrUlZxaEt3N3VQSTRaeUN1Wm9CamppSGRob1RCUmxmWndUUWt6bXlPY3N2Z2xrd1BFUmJYSDVTU0k4Y0VjMGNsdXZrSXhZd2V4ZVBBbVJwd2JicE5lVzVQWHJR?oc=5","date":"2024-11-25","type":"pipeline","source":"koreabiomed.com","summary":"Samyang Group appoints former ST Pharm CEO as president of biopharma unit - koreabiomed.com","headline":"Samyang Group appoints former ST Pharm CEO as president of biopharma unit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNWUQteENvX2l3YnZLZmxObzZ1dlQtWmNPYmM3TFNvOXRPMW52a3NvYnU1LXFQSGg2NEw3amlpQVo2dlJFdUtLRmxzNTdkWENWNnhjaXM5aENCMjdjbTNQVDgwRmdmbHpSXy1obHkwTmhqMXRibzBJS3dUcmJjTzJnT3RmRzdGVE1iNEV6bV94S09mNVlpMFp5ZTZIZ0d3MTA?oc=5","date":"2024-06-11","type":"pipeline","source":"BioWorld News","summary":"Abtis tapping ADC market with Claudin18.2-targeting AT-211 - BioWorld News","headline":"Abtis tapping ADC market with Claudin18.2-targeting AT-211","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOSEYzZUgtX0FESXFDOUpZdFZOdTB3TGdHNWFlczJpa2dKTUVhR0E1cXdUcnpwNjhqZkx1TXQ2d2ZNZ3FJLW1nYW9KOEFldHNSVWw5SUtjYzRWNkZnVHViT2g3SktRS05PR1JpMXQ2d2hONDZyMlAxbGx4TW5PaE9McU43U1NvMnByRGZyanVqSUZxdFQ1R2FtckIxUG5aOV8wd1FucmJZWVF0Wmd0MFBKeWlRQkg2bnZabkJV?oc=5","date":"2022-08-05","type":"trial","source":"European AIDS Treatment Group","summary":"ST Pharm presents Phase 1 clinical trial results of HIV treatment candidate at AIDS 2022 - European AIDS Treatment Group","headline":"ST Pharm presents Phase 1 clinical trial results of HIV treatment candidate at AIDS 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQaGtNVUs4a05YdjhkQVVmeVdGMXRYcGEtbjdlc3NUZXJZcVNXcXJ0aVlWLUZYWEVYRTJua1c0MVBUai1KVTVzRHBac05NRUlsVDR3dDhmN2FRVldLZktWOXJiV1l1UkhOZE1zWVF1dFk2eElaYV9HQ0phRXpGVVZqLWtTa19pNUIxa2lsaERzajhlZXc?oc=5","date":"2021-11-29","type":"pipeline","source":"Contract Pharma","summary":"ST Pharm to Expand Oligonucleotide Facility - Contract Pharma","headline":"ST Pharm to Expand Oligonucleotide Facility","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}